Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project

Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project

Abstract Background Chronic kidney disease has emerged as a strong cardiovascular risk factor, and in many current guidelines, it is already considered as a coronary heart disease (CHD) equivalent. Routinely, creatinine has been used as the main marker of renal function, but recently, cystatin C eme...

Full description

Bibliographic Details
Main Authors: Dietrich Rothenbacher, Martin Rehm, Licia Iacoviello, Simona Costanzo, Hugh Tunstall-Pedoe, Jill J. F. Belch, Stefan Söderberg, Johan Hultdin, Veikko Salomaa, Pekka Jousilahti, Allan Linneberg, Susana Sans, Teresa Padró, Barbara Thorand, Christa Meisinger, Frank Kee, Amy Jayne McKnight, Tarja Palosaari, Kari Kuulasmaa, Christoph Waldeyer, Tanja Zeller, Stefan Blankenberg, Wolfgang Koenig, on behalf of the BiomarCaRE consortium
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Medicine
Subjects:
Cohort study
Chronic kidney disease
Estimated glomerular filtration rate
Adverse outcome
Creatinine
Cystatin C
Online Access:http://link.springer.com/article/10.1186/s12916-020-01776-7

Internet

http://link.springer.com/article/10.1186/s12916-020-01776-7

Similar Items